PTSD Program
Post-Traumatic Stress Disorder
DiscoveryActive
Key Facts
About Ignite Biomedical
Ignite Biomedical is a private, pre-revenue biotech company pioneering an AI-driven approach to precision medicine. Its core technology is a quantitative AI platform used to de-risk and accelerate the discovery of mRNA-based diagnostics and precision drug targets, with active programs in immunology, autism, PTSD, and substance use disorder. The company's value proposition centers on drastically reducing diagnostic delays, improving treatment efficacy prediction, and condensing pre-clinical drug development timelines to 1-2 years. Its mission is to fulfill the broken promises of precision medicine by delivering pragmatic, patient-focused solutions.
View full company profileTherapeutic Areas
Other Post-Traumatic Stress Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| PTSD Studies | Pacific Clinical Research Medical Group | Phase 2/3 |
| Intranasal SPC-15 for PTSD (with Silo Pharma) | Resyca | Preclinical/CMC Development |